Neuraxis Inc (NRXS) - News Archive

In the rapidly evolving healthcare sector, NeurAxis Inc. (NYSE American: NRXS) is a notable player, focusing on the commercialization of neuromodulation therapies aimed at alleviating chronic ailments in both children a...

NeurAxis Expands Access to Percutaneous Electrical Nerve Field Stimulation with New Coverage Agreements in Pennsylvania and North DakotaCARMEL, Ind. — NeurAxis, Inc. (NYSE American: NRXS), a pioneering medical technolog...

NeurAxis, Inc. (NeurAxis), a leading medical technology company specializing in neuromodulation therapies for chronic conditions, has recently made a significant breakthrough. The company has announced the successful pu...

Over the past few years, the sphere of neuromodulation for medical therapy has undergone significant advancements, offering a new legion of therapeutic possibilities for diagnosing and treating chronic and debilitating...

NeurAxis, a leading medical technology company specializing in neuromodulation therapies for chronic and debilitating conditions, has recently announced a significant breakthrough in expanding patient access to its life...

NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy CoverageCARMEL, Ind., March 04, 2024 - NeurAxis, Inc. (NeurAxis), a leading medical technology company specializing in the commercialization of neuromo...

CARMEL, Ind., Dec. 20, 2023 NeurAxis, Inc. (NYSE American: NRXS), a renowned medical technology company specializing in neuromodulation therapies for chronic and debilitating conditions in both children and adults, rece...